New Cell Strainers Enable Superior Cell Preparations
Your solution for quick and easy filtration of single-cell suspensions
Your solution for quick and easy filtration of single-cell suspensions
Discover a comprehensive guide to real-time live-cell imaging and analysis
Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology
Find out about new tools and techniques to streamline biopharmaceutical analysis
Biotech scientist shares the importance of reliable technologies in the production of therapeutic proteins
Researchers reveal new insights into self repair pathways in cancer cells, after therapy with PARP inhibitors
Discover how scientists in Sweden and Finland are developing a functional systems precision medicine strategy to optimize treatment of acute myeloid leukemia
New 3D model provides options for drug development and treatment of gestational disorders
Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess
Discover how 3D models of glioblastoma using patient-derived stem cells could enable more effective treatment
Watch the product launch video for more information
AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities
SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells
Funding announced for the EU research project iConsensus
Algenuity launches multidisciplinary renewables biosynthesis project under Horizon 2020 programme
ScreenIn3D to offer platforms for personalized cancer treatment
Learn how a lab in the US is using cell culture methods to enhance the effectiveness of virus-like particles (VLPs) as novel vaccines against filoviruses
CRISPR-Cas9 found to induce p53 expression in cells